Williamson Robert F III's Form 4 filing
Perspective Therapeutics, Inc. (CATX) · filed Jan 30, 2024
- Accession no.
- 0001437749-24-002571
- Filed
- Jan 30, 2024
- Trade date
- Jan 26-29, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 0 derivative transactions. Open-market purchases total $78.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Williamson Robert F IIICIK 0001397331 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | Common Stock | PPurchaseAcquired | +12,250 | $0.61 | +$7,472.5 | 87,926 | Direct | |
| Jan 26, 2024 | Common Stock | PPurchaseAcquired | +14,850 | $0.61 | +$9,058.5 | 102,776 | Direct | |
| Jan 26, 2024 | Common Stock | PPurchaseAcquired | +8,513 | $0.59 | +$5,022.67 | 111,289 | Direct | |
| Jan 26, 2024 | Common Stock | PPurchaseAcquired | +25,000 | $0.55 | +$13,750 | 136,289 | Direct | |
| Jan 26, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $0.54 | +$27,000 | 186,289 | Direct | |
| Jan 29, 2024 | Common Stock | PPurchaseAcquired | +4,031 | $0.64 | +$2,579.84 | 190,320 | Direct | |
| Jan 29, 2024 | Common Stock | PPurchaseAcquired | +21,235 | $0.64 | +$13,590.4 | 211,555 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.